From the Editors
The September issue of The Oncology Pharmacist (TOP) features important information for today’s oncology pharmacist, including highlights from presentations made during the American Society of Clinical Oncology (ASCO) 2021 virtual meeting and other key oncology conferences.
The July issue of The Oncology Pharmacist (TOP) contains important information for today’s oncology pharmacist, including highlights from several presentations made during the 2021 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference and other key oncology meetings.
The May issue of The Oncology Pharmacist (TOP) contains important updates for today’s oncology pharmacist. These include highlights from recent national and international conferences, which explore recent advances in cancer treatment, as well as ongoing efforts to address social, economic, and policy issues affecting the delivery of healthcare.
The January issue of The Oncology Pharmacist (TOP) contains important news and updates for today’s oncology pharmacist, including highlights from recent national and international virtual conferences, exploring best practices in value-based performance in cancer care, strategies for providing high-quality and affordable care to patients during the COVID-19 pandemic, ongoing efforts to address social determinants of health and their effect on the delivery of healthcare, and the latest data on the safety and efficacy of novel agents and combination regimens for the treatment of patients with hematologic malignancies and solid tumors.
The November issue of The Oncology Pharmacist (TOP) features important news and insights for today’s oncology pharmacist, including highlights from recent virtual oncology conferences, which cover a range of topics, from efforts underway to improve access to treatment for individuals with cancer during the ongoing COVID-19 public health emergency, to safety and efficacy data on novel agents and combination regimens being used to improve outcomes in patients with hematologic malignancies or solid tumors.
The September issue of The Oncology Pharmacist (TOP) contains important news and insights for today’s oncology pharmacist, including highlights of recent virtual oncology conferences covering a range of topics, from strategies aimed at reducing drug costs and improving patient care, to the latest data on novel agents and combinations that are showing promise in the treatment of hematologic malignancies and solid tumors.
The July issue of The Oncology Pharmacist (TOP) is filled with important news and insights for today’s oncology pharmacist.
The May issue of The Oncology Pharmacist (TOP) is filled with important news and insights for today’s oncology pharmacist. We begin our coverage with highlights of a recent webinar from the Association for Value-Based Cancer Care (AVBCC), in which healthcare experts addressed the impact of the COVID-19 pandemic on oncology delivery systems and the management of patients with cancer.
The March issue of The Oncology Pharmacist (TOP) features the latest medical news, expert perspectives, clinical trial results, and drug updates, as well as important highlights from national and international meetings, including the 2019 ASH annual meeting, the 2019 Supportive Care in Oncology Symposium, the NCCN 2019 Hematologic Malignancies meeting, the ACCC 2019 National Oncology Conference, and the 2019 AVBCC Summit.
